Full-Time

Manufacturing Supervisor

August Bioservices

August Bioservices

51-200 employees

US-based CDMO for end-to-end drug development

No salary listed

Nashville, TN, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • 4+ years of cGMP manufacturing experience
  • previous supervisor experience preferred
  • Bachelor’s degree is preferred or equivalent pharma manufacturing experience
  • Must be able to qualify in Aseptic Grade A/B gowning
  • Ability to operate equipment utilized in aseptic operations, including HMI controls
  • Comprehensive knowledge of cGMP regulatory requirements for aseptic manufacturing
  • Demonstrated ability to troubleshoot, solve problems, synthesize data, summarize outcomes and provide recommendations on a compliant path forward, and own deviation investigations
  • Demonstrated ability to successfully execute responsibilities in a fast-paced environment, collaborating across corporate functions and multiple stakeholders
  • The ability to work flexible hours on short notice due to manufacturing demand
  • Self-starter and ability to work independently
  • Strong written/verbal communication and presentation skills
  • Team player with well-developed interpersonal skills and excellent organizational skills
  • Excellent computer skills in Microsoft Word, Excel, Outlook, and PowerPoint
Responsibilities
  • Accountable for production activities spanning equipment preparation, formulation, filling, packaging and other related processes. Primary container platforms include Vials, Syringes, Bags and Tubes
  • Responsible for execution of the manufacturing schedule and oversight and development of the team and related KPIs
  • Provides training, coaching, mentoring and discipline to team members to ensure development as individuals contributing to the goals of the department and company
  • Sets goals for team members to deliver the vision of the manufacturing operation aligned with site and company objectives
  • Leads deviation assessments and implements corrective actions (CAPAs)
  • Drives change controls for process improvement / changes or CAPAs
  • Establishes requirements and develops on-the-job-training plans for the Manufacturing team
  • Ensures personnel are qualified and proficient with applicable cGMP requirements and internal governing procedures
  • Maintains cleanroom environments to cGMP requirements
  • Develops and manages departmental goals and corresponding budget in alignment with the corporate and site goals
  • Expected to develop cross-functional knowledge and qualify on processes to support operations as needed

August Bioservices is a US-based CDMO offering end-to-end drug development and manufacturing from pre-clinical to commercial. It combines large-CDMO scale with a customer-focused hybrid model to serve startups and big pharma. It provides full development programs including research, development, testing, lab services, and sterile fill/finish under one integrated process, ensuring cGMP and FDA-quality standards. Its goal is to help clients bring safe, effective drugs to market efficiently through a seamless, integrated pathway.

Company Size

51-200

Company Stage

Series B

Total Funding

$88.6M

Headquarters

Nashville, Tennessee

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Severe scarcity in sterile injectable manufacturing capacity drives customer demand for expansion.
  • 77% revenue growth from 2023 to 2024 demonstrates strong market traction and scaling.
  • Fully automated downstream inspection and labeling processes increase throughput and operational efficiency.

What critics are saying

  • Larger CDMOs like Catalent and Thermo Fisher expand vial capacity, undercutting August's pricing.
  • 30-month equipment procurement timelines risk client attrition to faster-scaling competitors.
  • FDA cGMP non-compliance in new filling suite could halt commercial production immediately.

What makes August Bioservices unique

  • Focused sterile injectable CDMO with end-to-end services from development through commercialization.
  • CEO Jenn Adams recognized as Healthcare Technology CEO of the Year in March 2026.
  • Specialized expertise in poorly soluble, highly viscous compounds and uncommon container sizes.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at August Bioservices who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Relocation Assistance

Employee Referral Bonus

Student Loan Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Professional Development Budget

Conference Attendance Budget

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Wellness Program

Mental Health Support

Gym Membership

Commuter Benefits

Meal Benefits

Phone/Internet Stipend

Home Office Stipend

Legal Services

Employee Discounts

Company Social Events

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

1%

2 year growth

0%
The Healthcare Technology Report
Mar 18th, 2026
Jenn Adams named Healthcare Technology CEO of the Year.

Jenn Adams named Healthcare Technology CEO of the Year. Published. March 18, 2026 At this year's NYC Awards Night, The Healthcare Technology Repo had the privilege of recognizing several exceptional leaders advancing innovation across healthcare technology. Congratulations to Jenn Adams, CEO of August Bioservices, on being named Healthcare Technology CEO of the Year. Jenn has led August Bioservices since its founding in 2020, building a contract development and manufacturing organization (CDMO) dedicated to sterile injectable therapies. Headquartered in Nashville, the company provides development and manufacturing services that help drug developers advance innovative therapies from early development through commercialization. Accepting the award, Jenn shared: "When we started our company five and a half years ago, we had a really clear goal and we set out to build a CDMO focused on sterile injectables that could truly serve as a partner to our clients, providing deep technical expertise and a state-of-the-art facility and equipment - all designed to help advance innovative therapies through development and commercialization. Our aspiration is to show up so fully for our clients that they cannot tell the difference anymore. It's indistinguishable to them who is on their team and who is on our team because we're working shoulder to shoulder to make sure the drug is advanced. And then we're bridging the innovation and bringing it to patients who need that innovation in the form of therapies." Please join The Healthcare Technology Repo in congratulating Jenn Adams on this well-deserved recognition. Picture: Jenn Adams speaks at NYC Awards Night

Teknovation.biz
Dec 13th, 2024
Tennessee Emerges As A Leading State For Bioscience R&D

A new report from the Biotechnology Innovation Organization (BIO) and TEConomy Partners LLC finds Tennessee has emerged as a leading state for bioscience research and development, with bioscience RD accounting... The post Tennessee emerges as a leading state for bioscience RD appeared first on Teknovation.biz.

Teknovation.biz
Jun 30th, 2024
News & Notes | Ut Research Foundation Welcomes Four Interns

Like this story? Please share!News & Notes | UT Research Foundation welcomes four interns ETSU's Innovation Lab Director Dr. Audrey Depelteau served as a judge at last week's 2024 SelectUSA Investment Summit.From Knoxville:To promote the commercialization of University of Tennessee (UT) innovations and to help train the next generation of commercialization professionals, the UT Research Foundation (UTRF) recently welcomed three new interns and one returning intern across its Knoxville and Memphis offices.In Knoxville, Andrea Gutierrez-Cortez and Lauren Williams , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. Jacob Hale is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK.and , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK

Teknovation.biz
Oct 22nd, 2023
News & Notes | Expansion Bucks For August Bioservices

Like this story? Please share!. .

Teknovation.biz
Jan 23rd, 2023
Launch Tennessee Provides Ssbci Update, Q4 Tn Deal Flow

Like this story? Please share!. .